#39 - 📱 Your pocket just got smarter

Hey readers! 👋

This week, we're zooming in on how technology is making diabetes care more accessible than ever, whether you're at home, at school, or halfway around the world. From apps that turn your smartphone into a glucose command center to pumps launching in new regions, the theme is clear: diabetes management is becoming less about where you are and more about what tools you have in your pocket. Let's dive in!

The smartphone in your pocket keeps getting smarter about diabetes. Dexcom's mobile and smartwatch apps now let you view glucose levels 24/7, receive customizable alerts, and share data with up to ten followers or healthcare providers. The Dexcom Clarity app adds trend analysis and time-in-range metrics, while Dexcom Follow enables remote monitoring for family and friends. – Dexcom

Speaking of Dexcom, their over-the-counter Stelo CGM just got a major upgrade. Dexcom adds enhanced smart meal logging feature to Stelo CGM with an AI-powered nutrition database of over one million foods. Snap a photo, scan a barcode, or type a description, and you'll get calorie, carb, protein, fat, and fiber breakdowns. A redesigned Daily Insights feature delivers up to three personalized recommendations each day based on glucose, activity, nutrition, and sleep data. – Drug Delivery Business

The FreeStyle Libre smartphone app offers similar convenience, displaying real-time glucose readings, trend arrows, and up to 12 hours of historical data. Users can snap photos of meals or type descriptions, and the app predicts how food choices might affect glucose levels. – Abbott

For those who prefer an all-in-one solution, the Dario Blood Glucose Monitoring Starter Kit plugs directly into your smartphone, delivering accurate readings in under six seconds. The free app tracks glucose, carbs, medication, activity, and mood, and includes emergency hypo alerts with GPS. – Dario

Big news for the Middle East: Insulet launches Omnipod 5 and Omnipod Discover in Saudi Arabia, Kuwait, Qatar, and the UAE. The tubeless, waterproof automated insulin delivery system pairs with Abbott FreeStyle Libre 2 Plus and Dexcom G7 sensors. Alongside the device, Insulet introduced Omnipod Discover, a web-based analytics platform that simplifies data interpretation for users, caregivers, and clinicians. – Drug Delivery Business

The insulin delivery devices market is projected to reach US$43.11 billion by 2033, growing at 8.8% annually. Smart insulin pens, pumps, and CGM integration are driving this growth, with North America holding 40% market share, followed by Europe at 28% and Asia-Pacific at 24%. – DataM Intelligence

Medtronic wins expanded FDA label for 780G insulin pump, now compatible with ultra-rapid-acting insulins Fiasp and Lyumjev. The agency also cleared the 780G for use with Abbott's Instinct CGM in Type 2 diabetes, enabling Medicare coverage for the combined system. This could help reduce the impact of inexact carb counts and missed mealtime doses. – MedTech Dive

The Dexcom G7 15-Day CGM continues to expand access, with about 87% of insulin users and 50% of non-insulin users with commercial insurance now covered. Medicare covers all insulin users who meet criteria, and Dexcom offers a pharmacy savings program for those without coverage. – Dexcom

Kindness Goes a Long Way features Lauren, an assistant principal and mother of a six-year-old with T1D, discussing how she leveraged her position to educate teachers, nurses, and administrators. She created PowerPoint presentations, one-pager handouts, and regular text-group updates to ensure her son's needs were met safely during the school day. – Juicebox Podcast

In episode 1766, nurse-practitioner Danielle shares managing her daughter's new T1D diagnosis while caring for a newborn, emphasizing the critical role of mental health support for caregivers. – Juicebox Podcast

Eight-year-old Leah shares her experience with the Tandem Mobi pump, explaining how Control IQ Plus lets her input carbs on her phone and automatically calculates insulin, with exercise mode for soccer and dance. – Juicebox Podcast

Mayo Clinic is conducting 68 clinical studies covering pharmacologic, technological, and behavioral approaches to Type 1 diabetes, with major emphasis on closed-loop insulin delivery and CGM-based interventions. – Mayo Clinic

OPF-310 is testing encapsulated porcine islet cells that could eliminate the need for immunosuppression, with participants receiving travel reimbursement for out-of-state visits. – Breakthrough T1D

Made with ❤️ by Data Drift Press

Have questions, comments, or feedback? Hit reply - we'd love to hear from you!